


Healthcare News Roundup: Biopharmaceutical
HSMN NewsFeed - 2 Mar 2008
FDA Approves Aloxi(R) (Palonosetron HCL) Injection for Prevention of Postoperative Nausea and Vomiting
FDA Approves Aloxi(R) (Palonosetron HCL) Injection for Prevention of Postoperative Nausea and Vomiting
HSMN NewsFeed - 29 Feb 2008
AEterna Zentaris Announces the Departure of SVP, Administrative and Legal Affairs
AEterna Zentaris Announces the Departure of SVP, Administrative and Legal Affairs
HSMN NewsFeed - 29 Feb 2008
AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Major Depressive Disorder
AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Major Depressive Disorder
HSMN NewsFeed - 28 Feb 2008
Savient Provides Further Information on Top Line Phase 3 Trials Results for Puricase(R) (pegloticase)
Savient Provides Further Information on Top Line Phase 3 Trials Results for Puricase(R) (pegloticase)
HSMN NewsFeed - 28 Feb 2008
Procter & Gamble Wins Patent Infringement Lawsuit for Osteoporosis Therapy Actonel
Procter & Gamble Wins Patent Infringement Lawsuit for Osteoporosis Therapy Actonel
HSMN NewsFeed - 28 Feb 2008
FDA Approves NEXIUM(R) for the Treatment of Short-Term GERD in Children 1 to 11 Years Old
FDA Approves NEXIUM(R) for the Treatment of Short-Term GERD in Children 1 to 11 Years Old
HSMN NewsFeed - 28 Feb 2008
Kyowa Hakko Receives Not Approvable Letter from FDA for Istradefylline (KW-6002)
Kyowa Hakko Receives Not Approvable Letter from FDA for Istradefylline (KW-6002)
HSMN NewsFeed - 27 Feb 2008
EpiCept Announces Non-Binding Opinion by European Regulatory Authority on Ceplene Marketing Application
EpiCept Announces Non-Binding Opinion by European Regulatory Authority on Ceplene Marketing Application
HSMN NewsFeed - 27 Feb 2008
Michael J. Simms Joins Alexza Pharmaceuticals as Senior Vice President, Operations and Manufacturing
Michael J. Simms Joins Alexza Pharmaceuticals as Senior Vice President, Operations and Manufacturing
HSMN NewsFeed - 27 Feb 2008
APP Pharmaceuticals Receives Final Approval for Irinotecan Hydrochloride Injection
APP Pharmaceuticals Receives Final Approval for Irinotecan Hydrochloride Injection
HSMN NewsFeed - 27 Feb 2008
Forest Laboratories, Inc. Announces Amendment to Bystolic(TM) (nebivolol) Agreement
Forest Laboratories, Inc. Announces Amendment to Bystolic(TM) (nebivolol) Agreement
HSMN NewsFeed - 27 Feb 2008
Mylan Announces Appointment of Jagdish Dore' as CEO and Managing Director of Matrix Laboratories
Mylan Announces Appointment of Jagdish Dore' as CEO and Managing Director of Matrix Laboratories
HSMN NewsFeed - 27 Feb 2008
OVATION Appoints Christopher Silber, M.D. as Vice President, Clinical Affairs
OVATION Appoints Christopher Silber, M.D. as Vice President, Clinical Affairs
HSMN NewsFeed - 27 Feb 2008
Manhattan Pharmaceuticals Announces Closing of Joint Venture With Nordic Biotech
Manhattan Pharmaceuticals Announces Closing of Joint Venture With Nordic Biotech
HSMN NewsFeed - 27 Feb 2008
Covidien Announces Tentative FDA Approval for Its Generic Myocardial Perfusion Imaging Kit
Covidien Announces Tentative FDA Approval for Its Generic Myocardial Perfusion Imaging Kit
HSMN NewsFeed - 27 Feb 2008
M. Scott Harris, M.D., Joins Ocera Therapeutics, Inc., as Chief Medical Officer
M. Scott Harris, M.D., Joins Ocera Therapeutics, Inc., as Chief Medical Officer
HSMN NewsFeed - 26 Feb 2008
Ambrx Appoints Douglas Axelrod Senior Vice President for Clinical Research and Development
Ambrx Appoints Douglas Axelrod Senior Vice President for Clinical Research and Development
HSMN NewsFeed - 26 Feb 2008
Synthetic Blood Announces Department of Defense Grant for Traumatic Brain Injury Clinical Trial with Oxycyte
Synthetic Blood Announces Department of Defense Grant for Traumatic Brain Injury Clinical Trial with Oxycyte
HSMN NewsFeed - 26 Feb 2008
CollaGenex Pharmaceuticals Signs Merger Agreement with Galderma Pharma S.A.
CollaGenex Pharmaceuticals Signs Merger Agreement with Galderma Pharma S.A.
HSMN NewsFeed - 25 Feb 2008
Genentech Receives Notification of Rejection of Cabilly Patent Claims From Reexamination Process
Genentech Receives Notification of Rejection of Cabilly Patent Claims From Reexamination Process
HSMN NewsFeed - 25 Feb 2008
Proteolix Names Matthew Ferguson to Newly-Created Position of Chief Financial Officer
Proteolix Names Matthew Ferguson to Newly-Created Position of Chief Financial Officer
HSMN NewsFeed - 25 Feb 2008
Pfizer Voluntarily Withdraws Lipitor Advertising Featuring Dr. Robert Jarvik
Pfizer Voluntarily Withdraws Lipitor Advertising Featuring Dr. Robert Jarvik
HSMN NewsFeed - 25 Feb 2008
GPC Biotech Announces Corporate Restructuring and Provides Pipeline Update
GPC Biotech Announces Corporate Restructuring and Provides Pipeline Update
HSMN NewsFeed - 25 Feb 2008
Mylan Announces Appointment of Eric M. Leeds as Senior Vice President and Head of Global Investor Relations
Mylan Announces Appointment of Eric M. Leeds as Senior Vice President and Head of Global Investor Relations
HSMN NewsFeed - 25 Feb 2008
Alexza Initiates First Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine)
Alexza Initiates First Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine)
HSMN NewsFeed - 25 Feb 2008
Teva Announces Two Court Decisions to Revoke MSD's European Patent on Generic Fosamax(R)
Teva Announces Two Court Decisions to Revoke MSD's European Patent on Generic Fosamax(R)
HSMN NewsFeed - 25 Feb 2008
Marillion Pharmaceuticals and Cytokine PharmaSciences Announce License Agreement for Xerostomia Treatment
Marillion Pharmaceuticals and Cytokine PharmaSciences Announce License Agreement for Xerostomia Treatment
HSMN NewsFeed - 22 Feb 2008
Sucampo Pharmaceuticals Appoints John C. Wright, Retired Ernst & Young Partner, to Board of Directors
Sucampo Pharmaceuticals Appoints John C. Wright, Retired Ernst & Young Partner, to Board of Directors
HSMN NewsFeed - 22 Feb 2008
Abbott Receives FDA Approval for HUMIRA(R) (Adalimumab) for Polyarticular Juvenile Idiopathic Arthritis
Abbott Receives FDA Approval for HUMIRA(R) (Adalimumab) for Polyarticular Juvenile Idiopathic Arthritis
HSMN NewsFeed - 22 Feb 2008
Kiadis Pharma Obtains FDA Approval to Start a Phase III Clinical Trial for Reviroc(TM) in the United States
Kiadis Pharma Obtains FDA Approval to Start a Phase III Clinical Trial for Reviroc(TM) in the United States
HSMN NewsFeed - 21 Feb 2008
Human Genome Sciences Appoints Maxine Gowen, Ph.D., to Its Board Of Directors
Human Genome Sciences Appoints Maxine Gowen, Ph.D., to Its Board Of Directors
HSMN NewsFeed - 21 Feb 2008
Talecris Biotherapeutics Celebrates 20th Anniversary of Launch of Prolastin(R)
Talecris Biotherapeutics Celebrates 20th Anniversary of Launch of Prolastin(R)
HSMN NewsFeed - 21 Feb 2008
Sciele Pharma and LifeCycle Pharma Announce U.S. Market Launch of Fenoglide(TM)
Sciele Pharma and LifeCycle Pharma Announce U.S. Market Launch of Fenoglide(TM)
HSMN NewsFeed - 21 Feb 2008
ImmunoCellular Therapeutics Announces New President and Chief Executive Officer
ImmunoCellular Therapeutics Announces New President and Chief Executive Officer
HSMN NewsFeed - 20 Feb 2008
Cook Pharmica Names Fred Larimore, Ph.D., Vice President of Scientific Affairs, CSO
Cook Pharmica Names Fred Larimore, Ph.D., Vice President of Scientific Affairs, CSO
HSMN NewsFeed - 20 Feb 2008
Millennium Expands VELCADE(R) (Bortezomib) For Injection Program In Non-Hodgkin's Lymphoma
Millennium Expands VELCADE(R) (Bortezomib) For Injection Program In Non-Hodgkin's Lymphoma
HSMN NewsFeed - 20 Feb 2008
New Breakthrough Treatment for Advanced Kidney Cancer Shows 49 Per Cent Higher Survival Rates
New Breakthrough Treatment for Advanced Kidney Cancer Shows 49 Per Cent Higher Survival Rates
HSMN NewsFeed - 20 Feb 2008
MacuSight Expands Management Team With Appointment of Dr. Joel Naor as Chief Medical Officer
MacuSight Expands Management Team With Appointment of Dr. Joel Naor as Chief Medical Officer
HSMN NewsFeed - 20 Feb 2008
Neurobiological Technologies Reports $2.1 Million Quarterly Payment for Sales of Memantine
Neurobiological Technologies Reports $2.1 Million Quarterly Payment for Sales of Memantine
HSMN NewsFeed - 19 Feb 2008
Barr Receives Final Approval for Generic Mirapex(R) Tablets, 0.125mg, 0.25mg, 0.5mg, 1mg & 1.5mg
Barr Receives Final Approval for Generic Mirapex(R) Tablets, 0.125mg, 0.25mg, 0.5mg, 1mg & 1.5mg
HSMN NewsFeed - 19 Feb 2008
Novo Nordisk Consolidates U.S. Diabetes Sales Leadership Under Single Vice President
Novo Nordisk Consolidates U.S. Diabetes Sales Leadership Under Single Vice President
HSMN NewsFeed - 19 Feb 2008
Novavax Enters Into Estrasorb(R) Asset Sale and Supply Agreements with Graceway Pharmaceuticals, LLC
Novavax Enters Into Estrasorb(R) Asset Sale and Supply Agreements with Graceway Pharmaceuticals, LLC
HSMN NewsFeed - 19 Feb 2008
FDA Accepts TREANDA(R) New Drug Application for the Treatment of Relapsed Indolent Non-Hodgkin's Lymphoma
FDA Accepts TREANDA(R) New Drug Application for the Treatment of Relapsed Indolent Non-Hodgkin's Lymphoma
HSMN NewsFeed - 19 Feb 2008
Lenalidomide (REVLIMID(R)) Receives Orphan Drug Status in Japan for Multiple Indications
Lenalidomide (REVLIMID(R)) Receives Orphan Drug Status in Japan for Multiple Indications
HSMN NewsFeed - 19 Feb 2008
Santarus Announces Launch of ZEGERID Products by GlaxoSmithKline in Puerto Rico and U.S. Virgin Islands
Santarus Announces Launch of ZEGERID Products by GlaxoSmithKline in Puerto Rico and U.S. Virgin Islands
HSMN NewsFeed - 18 Feb 2008
Paladin Labs & KV Pharmaceuticals Sign Distribution For Micro-K(R) Extencaps(R) Capsules
Paladin Labs & KV Pharmaceuticals Sign Distribution For Micro-K(R) Extencaps(R) Capsules
HSMN NewsFeed - 18 Feb 2008
Bayer and Onyx Provide Update on Phase 3 Trial of Nexavar in Patients With Non-Small Cell Lung Cancer
Bayer and Onyx Provide Update on Phase 3 Trial of Nexavar in Patients With Non-Small Cell Lung Cancer
HSMN NewsFeed - 14 Feb 2008
BiPar Names Hoyoung Huh, M.D., Ph.D. President and Chief Executive Officer
BiPar Names Hoyoung Huh, M.D., Ph.D. President and Chief Executive Officer
HSMN NewsFeed - 14 Feb 2008
Dendreon Presents Data Correlating the Cumulative Potency of PROVENGE(R) to Overall Survival
Dendreon Presents Data Correlating the Cumulative Potency of PROVENGE(R) to Overall Survival
HSMN NewsFeed - 13 Feb 2008
Bioniche Provides Update on Refractory Bladder Cancer Trial with Urocidin(TM)
Bioniche Provides Update on Refractory Bladder Cancer Trial with Urocidin(TM)
HSMN NewsFeed - 13 Feb 2008
Shire's ELAPRASE(R) (idursulfase) Approved in Mexico for Treatment of Hunter Syndrome
Shire's ELAPRASE(R) (idursulfase) Approved in Mexico for Treatment of Hunter Syndrome
HSMN NewsFeed - 12 Feb 2008
Bristol-Myers Squibb Board Elects James M. Cornelius Chairman of the Board
Bristol-Myers Squibb Board Elects James M. Cornelius Chairman of the Board
HSMN NewsFeed - 12 Feb 2008
Sapphire Therapeutics Promotes Suzan Allen to Vice President Clinical Operations
Sapphire Therapeutics Promotes Suzan Allen to Vice President Clinical Operations
HSMN NewsFeed - 12 Feb 2008
Nektar Announces Restructuring to Complete Its Transition to a Therapeutics Drug Development Organization
Nektar Announces Restructuring to Complete Its Transition to a Therapeutics Drug Development Organization
HSMN NewsFeed - 12 Feb 2008
Mersana Therapeutics, Inc. Appoints Chief Scientific Officer, Timothy B. Lowinger, Ph.D.
Mersana Therapeutics, Inc. Appoints Chief Scientific Officer, Timothy B. Lowinger, Ph.D.
HSMN NewsFeed - 12 Feb 2008
Ipsen: Clinical Update For Decapeptyl(R) 6-Month Formulation in Advanced Prostate Cancer
Ipsen: Clinical Update For Decapeptyl(R) 6-Month Formulation in Advanced Prostate Cancer
HSMN NewsFeed - 12 Feb 2008
Clinical Update - Decapeptyl(R)/Trelstar(R) 6-Month Formulation in Advanced Prostate Cancer
Clinical Update - Decapeptyl(R)/Trelstar(R) 6-Month Formulation in Advanced Prostate Cancer
HSMN NewsFeed - 11 Feb 2008
Hi-Tech Pharmacal Receives Approval for Hydrocodone Bitartrate and Homatropine Methylbromide Syrup
Hi-Tech Pharmacal Receives Approval for Hydrocodone Bitartrate and Homatropine Methylbromide Syrup
HSMN NewsFeed - 11 Feb 2008
Regulus Therapeutics Appoints Peter S. Linsley, Ph.D. as Chief Scientific Officer
Regulus Therapeutics Appoints Peter S. Linsley, Ph.D. as Chief Scientific Officer
HSMN NewsFeed - 11 Feb 2008
La Jolla Pharmaceutical Company Reports Progress in International Phase 3 Riquent(R) Study
La Jolla Pharmaceutical Company Reports Progress in International Phase 3 Riquent(R) Study
HSMN NewsFeed - 11 Feb 2008
New Data Shows DAVANAT(R) Extends Survival of End-Stage Colorectal Cancer Patients More Than 6 Months
New Data Shows DAVANAT(R) Extends Survival of End-Stage Colorectal Cancer Patients More Than 6 Months
HSMN NewsFeed - 11 Feb 2008
SciClone and Sigma-Tau Report Promising Interim Results From Phase 3 Hepatitis C Trial
SciClone and Sigma-Tau Report Promising Interim Results From Phase 3 Hepatitis C Trial
HSMN NewsFeed - 8 Feb 2008
Solstice Neurosciences, Inc. Issues Corporate Response to FDA Early Communication
Solstice Neurosciences, Inc. Issues Corporate Response to FDA Early Communication
HSMN NewsFeed - 8 Feb 2008
Schering-Plough Announces Organizational Changes at Schering-Plough Research Institute
Schering-Plough Announces Organizational Changes at Schering-Plough Research Institute
HSMN NewsFeed - 8 Feb 2008
APP Pharmaceuticals Receives FDA Approval for Bleomycin Sulfate for Injection, USP
APP Pharmaceuticals Receives FDA Approval for Bleomycin Sulfate for Injection, USP
HSMN NewsFeed - 8 Feb 2008
APP Pharmaceuticals Receives FDA Approval for Caffeine Citrate Oral Solution, USP
APP Pharmaceuticals Receives FDA Approval for Caffeine Citrate Oral Solution, USP
HSMN NewsFeed - 8 Feb 2008
Synthetic Blood Announces Medical Advisory Board Meeting Results, New Additions to Board
Synthetic Blood Announces Medical Advisory Board Meeting Results, New Additions to Board
HSMN NewsFeed - 7 Feb 2008
Ranbaxy Receives Tentative Approval to Manufacture and Market Esomeprazole Magnesium DR Capsules
Ranbaxy Receives Tentative Approval to Manufacture and Market Esomeprazole Magnesium DR Capsules
HSMN NewsFeed - 7 Feb 2008
Koronis Pharmaceuticals Appoints David Drajeske Director of Business Development
Koronis Pharmaceuticals Appoints David Drajeske Director of Business Development
HSMN NewsFeed - 7 Feb 2008
EpiCept Announces Encouraging Results of Phase II Trial for NP-1 Cream in Diabetic Peripheral Neuropathy
EpiCept Announces Encouraging Results of Phase II Trial for NP-1 Cream in Diabetic Peripheral Neuropathy
HSMN NewsFeed - 6 Feb 2008
CorMedix Licenses New Technology to Prevent Infection and Clots in Central Venous Catheters
CorMedix Licenses New Technology to Prevent Infection and Clots in Central Venous Catheters
HSMN NewsFeed - 6 Feb 2008
Cook Pharmica Announces $80 Million Expansion to its Bloomington Biopharmaceutical Facility
Cook Pharmica Announces $80 Million Expansion to its Bloomington Biopharmaceutical Facility
HSMN NewsFeed - 6 Feb 2008
Teva Announces Approval of Generic Fosamax(R) Tablets, 5 mg, 10 mg, 35 mg, 40 mg and 70 mg
Teva Announces Approval of Generic Fosamax(R) Tablets, 5 mg, 10 mg, 35 mg, 40 mg and 70 mg
HSMN NewsFeed - 6 Feb 2008
Ranbaxy Gains Approval to Manufacture and Market Cefuroxime Axetil for Oral Suspension
Ranbaxy Gains Approval to Manufacture and Market Cefuroxime Axetil for Oral Suspension
HSMN NewsFeed - 6 Feb 2008
Apex Bioventures and Dynogen Pharmaceuticals Announce Definitive Merger Agreement
Apex Bioventures and Dynogen Pharmaceuticals Announce Definitive Merger Agreement
HSMN NewsFeed - 6 Feb 2008
FDA Agrees to Review Cimzia(R) File for the Treatment of Rheumatoid Arthritis
FDA Agrees to Review Cimzia(R) File for the Treatment of Rheumatoid Arthritis
HSMN NewsFeed - 5 Feb 2008
Insmed Launches National Awareness Campaign Surrounding Follow-On Biologics
Insmed Launches National Awareness Campaign Surrounding Follow-On Biologics
HSMN NewsFeed - 5 Feb 2008
Insmed CEO Issues Statement on White House FY09 Budget and FDA Statements on Follow-On Biologics
Insmed CEO Issues Statement on White House FY09 Budget and FDA Statements on Follow-On Biologics
HSMN NewsFeed - 4 Feb 2008
EKR Therapeutics and PDL BioPharma Sign Asset Purchase Agreement for Cardiovascular Products
EKR Therapeutics and PDL BioPharma Sign Asset Purchase Agreement for Cardiovascular Products
HSMN NewsFeed - 4 Feb 2008
Traversa Raises $2M to Advance RNAi Delivery in Angel-Led Series A Financing
Traversa Raises $2M to Advance RNAi Delivery in Angel-Led Series A Financing
HSMN NewsFeed - 4 Feb 2008
Infinity and MedImmune Announce Approval for Generic Name for Novel Hsp90 Inhibitor
Infinity and MedImmune Announce Approval for Generic Name for Novel Hsp90 Inhibitor
HSMN NewsFeed - 4 Feb 2008
Centocor Announces Ustekinumab Biologic License Application Accepted for Filing by FDA
Centocor Announces Ustekinumab Biologic License Application Accepted for Filing by FDA
HSMN NewsFeed - 4 Feb 2008
Steven Steinhubl, MD, Joins The Medicines Company as Global Vice President, Thrombosis
Steven Steinhubl, MD, Joins The Medicines Company as Global Vice President, Thrombosis
HSMN NewsFeed - 4 Feb 2008
Promedior Adds to Management Team and Announces Extension of Series A Financing
Promedior Adds to Management Team and Announces Extension of Series A Financing
HSMN NewsFeed - 4 Feb 2008
Poniard Pharmaceuticals Appoints Robert De Jager, M.D., as Chief Medical Officer
Poniard Pharmaceuticals Appoints Robert De Jager, M.D., as Chief Medical Officer
HSMN NewsFeed - 4 Feb 2008
Neurogen Corporation Announces Appointment of Stephen R. Davis as President & CEO
Neurogen Corporation Announces Appointment of Stephen R. Davis as President & CEO
HSMN NewsFeed - 4 Feb 2008
Amgen and Takeda Announce Exclusive Collaboration in Japan on up to 13 Amgen Clinical Candidates
Amgen and Takeda Announce Exclusive Collaboration in Japan on up to 13 Amgen Clinical Candidates
HSMN NewsFeed - 1 Feb 2008
Biovail Receives Letter Related to 2003 Cardizem(R) LA Launch Activities from U.S. Attorney's Office
Biovail Receives Letter Related to 2003 Cardizem(R) LA Launch Activities from U.S. Attorney's Office
HSMN NewsFeed - 1 Feb 2008
Canadian Marketing and Sales Effort for Labopharm's Once-Daily Tramadol Product to Expand Significantly
Canadian Marketing and Sales Effort for Labopharm's Once-Daily Tramadol Product to Expand Significantly
HSMN NewsFeed - 1 Feb 2008
MediciNova's MN-166 Reduces Persistent Black Hole Formation in Multiple Sclerosis Patients
MediciNova's MN-166 Reduces Persistent Black Hole Formation in Multiple Sclerosis Patients
HSMN NewsFeed - 31 Jan 2008
Somaxon Pharmaceuticals Submits New Drug Application for SILENOR(TM) for the Treatment of Insomnia
Somaxon Pharmaceuticals Submits New Drug Application for SILENOR(TM) for the Treatment of Insomnia
HSMN NewsFeed - 31 Jan 2008
Sonexa Therapeutics, Inc., Raises $30 Million in Series A Financing to Focus on Alzheimer's Treatments
Sonexa Therapeutics, Inc., Raises $30 Million in Series A Financing to Focus on Alzheimer's Treatments
HSMN NewsFeed - 31 Jan 2008
Ipsen: FDA Accepts for Filing a Biologics License Application (BLA) for Dysport(R) in Cervical Dystonia
Ipsen: FDA Accepts for Filing a Biologics License Application (BLA) for Dysport(R) in Cervical Dystonia
HSMN NewsFeed - 30 Jan 2008
Stephen Hill, ArQule President and CEO, to Join Solvay Pharmaceuticals, Inc. as New President and CEO
Stephen Hill, ArQule President and CEO, to Join Solvay Pharmaceuticals, Inc. as New President and CEO
HSMN NewsFeed - 30 Jan 2008
Prasco to Distribute Wyeth's Own Generic Versions of Protonix(R) Delayed-Release Tablets
Prasco to Distribute Wyeth's Own Generic Versions of Protonix(R) Delayed-Release Tablets
HSMN NewsFeed - 30 Jan 2008
Lux Granted Fast Track Designation for LX201 for Corneal Transplant Rejection
Lux Granted Fast Track Designation for LX201 for Corneal Transplant Rejection
HSMN NewsFeed - 30 Jan 2008
Iroko Pharmaceuticals Acquires Rights to Cardiovascular Product from Merck & Co., Inc.
Iroko Pharmaceuticals Acquires Rights to Cardiovascular Product from Merck & Co., Inc.
HSMN NewsFeed - 30 Jan 2008
IMPAX Receives FDA Non-Approvable Letter for Vadova(R); Company Considering Options
IMPAX Receives FDA Non-Approvable Letter for Vadova(R); Company Considering Options
HSMN NewsFeed - 30 Jan 2008
Reckitt Benckiser Completes Acquisition of Adams Respiratory Therapeutics, Inc.
Reckitt Benckiser Completes Acquisition of Adams Respiratory Therapeutics, Inc.
HSMN NewsFeed - 30 Jan 2008
Anesiva Announces Hiring of Sales Force for FDA-Approved Product Zingo(TM)
Anesiva Announces Hiring of Sales Force for FDA-Approved Product Zingo(TM)
HSMN NewsFeed - 30 Jan 2008
Akorn, Inc. Announces FDA Approval of Calcitriol Injection, 1 mcg/mL and 2 mcg/mL
Akorn, Inc. Announces FDA Approval of Calcitriol Injection, 1 mcg/mL and 2 mcg/mL
HSMN NewsFeed - 29 Jan 2008
Anika Therapeutics Appoints Andrew J. Carter, Ph.D., as Chief Technology Officer
Anika Therapeutics Appoints Andrew J. Carter, Ph.D., as Chief Technology Officer
HSMN NewsFeed - 29 Jan 2008
KaloBios Strengthens Development Expertise With Additions to Senior Management Team
KaloBios Strengthens Development Expertise With Additions to Senior Management Team
HSMN NewsFeed - 29 Jan 2008
BioSante Pharmaceuticals Announces FDA Special Protocol Assessment (SPA) for LibiGel(R) in FSD
BioSante Pharmaceuticals Announces FDA Special Protocol Assessment (SPA) for LibiGel(R) in FSD
HSMN NewsFeed - 29 Jan 2008
Pipex Pharmaceuticals Provides Update on COPREXA (Oral Tetrathiomolybdate) New Drug Application
Pipex Pharmaceuticals Provides Update on COPREXA (Oral Tetrathiomolybdate) New Drug Application
HSMN NewsFeed - 28 Jan 2008
Pfizer Japan Receives Manufacturing and Marketing Authorization for Champix(R)
Pfizer Japan Receives Manufacturing and Marketing Authorization for Champix(R)
HSMN NewsFeed - 28 Jan 2008
Cylene Pharmaceuticals Appoints Kenna Anderes, Ph.D. as Vice President of Cancer Biology
Cylene Pharmaceuticals Appoints Kenna Anderes, Ph.D. as Vice President of Cancer Biology
HSMN NewsFeed - 28 Jan 2008
Allos Therapeutics Appoints Bruce K. Bennett as Vice President, Manufacturing
Allos Therapeutics Appoints Bruce K. Bennett as Vice President, Manufacturing
HSMN NewsFeed - 28 Jan 2008
Synta and GlaxoSmithKline Announce Elesclomol Granted Orphan Drug Designation by the FDA
Synta and GlaxoSmithKline Announce Elesclomol Granted Orphan Drug Designation by the FDA
HSMN NewsFeed - 25 Jan 2008
Baxter Issues Urgent Nationwide Voluntary Recall of Heparin 1,000 Units/mL 10 and 30mL Multi-Dose Vials
Baxter Issues Urgent Nationwide Voluntary Recall of Heparin 1,000 Units/mL 10 and 30mL Multi-Dose Vials
HSMN NewsFeed - 25 Jan 2008
Cephalon Provides Update on Regulatory Status of the FENTORA Supplemental New Drug Application
Cephalon Provides Update on Regulatory Status of the FENTORA Supplemental New Drug Application
HSMN NewsFeed - 25 Jan 2008
Over 30 New Studies of Oral Xeloda(R) Featured at the 2008 Gastrointestinal Cancers Symposium
Over 30 New Studies of Oral Xeloda(R) Featured at the 2008 Gastrointestinal Cancers Symposium
HSMN NewsFeed - 25 Jan 2008
Dr. Thomas Okarma Resumes Direct Leadership of Geron's Oncology Drug Development Activities
Dr. Thomas Okarma Resumes Direct Leadership of Geron's Oncology Drug Development Activities
HSMN NewsFeed - 25 Jan 2008
Merck and Schering-Plough Respond To Issues Raised About ENHANCE Clinical Trial
Merck and Schering-Plough Respond To Issues Raised About ENHANCE Clinical Trial
HSMN NewsFeed - 25 Jan 2008
ImaRx Therapeutics Receives Urokinase Lot Release Approval With Extended Expiration Dating
ImaRx Therapeutics Receives Urokinase Lot Release Approval With Extended Expiration Dating
HSMN NewsFeed - 24 Jan 2008
Ash Access Technology, Inc. Completes Patient Enrollment in AZEPTIC Trial for Zuragen(R)
Ash Access Technology, Inc. Completes Patient Enrollment in AZEPTIC Trial for Zuragen(R)
HSMN NewsFeed - 24 Jan 2008
Labopharm Receives FDA Response To Recent Appeal Of Approvable Letter For Once-Daily Tramadol
Labopharm Receives FDA Response To Recent Appeal Of Approvable Letter For Once-Daily Tramadol
HSMN NewsFeed - 24 Jan 2008
FDA Approves MiddleBrook's Amoxicillin PULSYS for Pharyngitis/Tonsillitis in Adolescents and Adults
FDA Approves MiddleBrook's Amoxicillin PULSYS for Pharyngitis/Tonsillitis in Adolescents and Adults
HSMN NewsFeed - 23 Jan 2008
Teva Announces Tentative Approval of Generic Prevacid(R) Delayed-Release Capsules
Teva Announces Tentative Approval of Generic Prevacid(R) Delayed-Release Capsules
HSMN NewsFeed - 23 Jan 2008
Carol L. Brosgart, M.D., Appointed to the Board of Directors of Juvaris BioTherapeutics, Inc.
Carol L. Brosgart, M.D., Appointed to the Board of Directors of Juvaris BioTherapeutics, Inc.
HSMN NewsFeed - 23 Jan 2008
Robert A. Scott, M.D., Appointed Chief Medical Officer of Cerenis Therapeutics
Robert A. Scott, M.D., Appointed Chief Medical Officer of Cerenis Therapeutics
HSMN NewsFeed - 23 Jan 2008
Michael L. Salgaller, Ph.D., Appointed Chief Operating Officer of Calibrant Biosystems
Michael L. Salgaller, Ph.D., Appointed Chief Operating Officer of Calibrant Biosystems
HSMN NewsFeed - 22 Jan 2008
Nabi Biopharmaceuticals Names Dr. Raafat E.F. Fahim as President and Chief Executive Officer
Nabi Biopharmaceuticals Names Dr. Raafat E.F. Fahim as President and Chief Executive Officer
HSMN NewsFeed - 22 Jan 2008
Samaritan Hires Expert Marketing Specialist to Build Up Southeast Europe Sales
Samaritan Hires Expert Marketing Specialist to Build Up Southeast Europe Sales
HSMN NewsFeed - 22 Jan 2008
Steve Glass Appointed Vice President and General Manager, BioMarin Europe, Ltd.
Steve Glass Appointed Vice President and General Manager, BioMarin Europe, Ltd.
HSMN NewsFeed - 22 Jan 2008
Palatin Technologies Announces Litigation Settlement With Competitive Technologies
Palatin Technologies Announces Litigation Settlement With Competitive Technologies
HSMN NewsFeed - 22 Jan 2008
Taro Receives FDA Approval of New Drug Application for Flo-Pred(TM) (Prednisolone Acetate Oral Suspension)
Taro Receives FDA Approval of New Drug Application for Flo-Pred(TM) (Prednisolone Acetate Oral Suspension)
HSMN NewsFeed - 22 Jan 2008
RxElite Appoints Rick Schindewolf Vice President for Business Development
RxElite Appoints Rick Schindewolf Vice President for Business Development
HSMN NewsFeed - 22 Jan 2008
Abraxis Receives Approval from EU Commission to Market ABRAXANE for Metastatic Breast Cancer in Europe
Abraxis Receives Approval from EU Commission to Market ABRAXANE for Metastatic Breast Cancer in Europe
HSMN NewsFeed - 22 Jan 2008
Exelixis and Bristol-Myers Squibb to Co-Develop XL139, an Inhibitor of the Hedgehog Pathway
Exelixis and Bristol-Myers Squibb to Co-Develop XL139, an Inhibitor of the Hedgehog Pathway
HSMN NewsFeed - 21 Jan 2008
Welchol(TM) (colesevelam HCl) Receives FDA Approval to Reduce Blood Glucose in Adults With Type 2 Diabetes
Welchol(TM) (colesevelam HCl) Receives FDA Approval to Reduce Blood Glucose in Adults With Type 2 Diabetes
HSMN NewsFeed - 21 Jan 2008
Ranbaxy Announces Settlement of Possible Imitrex(R) Litigation With GlaxoSmithKline
Ranbaxy Announces Settlement of Possible Imitrex(R) Litigation With GlaxoSmithKline
HSMN NewsFeed - 21 Jan 2008
Dr. Reddy's Announces Settlement of Exelon(R) (rivastigmine tartrate) ANDA Litigation With Novartis
Dr. Reddy's Announces Settlement of Exelon(R) (rivastigmine tartrate) ANDA Litigation With Novartis
HSMN NewsFeed - 19 Jan 2008
Abbott's HUMIRA(R) (adalimumab) Receives FDA Approval For Moderate to Severe Chronic Plaque Psoriasis
Abbott's HUMIRA(R) (adalimumab) Receives FDA Approval For Moderate to Severe Chronic Plaque Psoriasis
HSMN NewsFeed - 19 Jan 2008
Welchol(TM) (colesevelam HCl) Receives FDA Approval to Reduce Blood Glucose in Adults with Type 2 Diabetes
Welchol(TM) (colesevelam HCl) Receives FDA Approval to Reduce Blood Glucose in Adults with Type 2 Diabetes
HSMN NewsFeed - 18 Jan 2008
Alba Therapeutics Appoints Wendy Perrow as its Vice President, Marketing and Alliance Management
Alba Therapeutics Appoints Wendy Perrow as its Vice President, Marketing and Alliance Management
HSMN NewsFeed - 18 Jan 2008
Pfizer Statement on CHANTIX (varenicline) Labeling Update in the United States
Pfizer Statement on CHANTIX (varenicline) Labeling Update in the United States
HSMN NewsFeed - 18 Jan 2008
Derma Sciences Expands Direct Sales Force for Advanced Wound Care, Looks to Double Again in 2008
Derma Sciences Expands Direct Sales Force for Advanced Wound Care, Looks to Double Again in 2008
HSMN NewsFeed - 17 Jan 2008
Eisai and MGI PHARMA Announce Early Termination of HSR Waiting Period for Eisai's Acquisition of MGI PHARMA
Eisai and MGI PHARMA Announce Early Termination of HSR Waiting Period for Eisai's Acquisition of MGI PHARMA
HSMN NewsFeed - 17 Jan 2008
Oculus Innovative Sciences, Inc. Appoints Gregg Alton to its Board of Directors
Oculus Innovative Sciences, Inc. Appoints Gregg Alton to its Board of Directors
HSMN NewsFeed - 17 Jan 2008
APP Pharmaceuticals Receives FDA Approval for Polymyxin B Sulfate for Injection, USP
APP Pharmaceuticals Receives FDA Approval for Polymyxin B Sulfate for Injection, USP
HSMN NewsFeed - 17 Jan 2008
Shire Completes Fosrenol(R) Roll-Out in Major European Markets With Launch in Spain
Shire Completes Fosrenol(R) Roll-Out in Major European Markets With Launch in Spain
HSMN NewsFeed - 16 Jan 2008
Recordati Licenses Kentera(R) From Watson Pharmaceuticals Inc. (U.S.A.) for Europe
Recordati Licenses Kentera(R) From Watson Pharmaceuticals Inc. (U.S.A.) for Europe
HSMN NewsFeed - 16 Jan 2008
Hi-Tech Pharmacal Receives Final Approval for Fluticasone Propionate Nasal Spray, 50mcg
Hi-Tech Pharmacal Receives Final Approval for Fluticasone Propionate Nasal Spray, 50mcg
HSMN NewsFeed - 16 Jan 2008
VIA Pharmaceuticals Names Rebecca Taub Senior Vice President of Research and Development
VIA Pharmaceuticals Names Rebecca Taub Senior Vice President of Research and Development
HSMN NewsFeed - 16 Jan 2008
Hospitals, Healthcare Providers Will Save with New Premier Agreement for Medication Assistance Services
Hospitals, Healthcare Providers Will Save with New Premier Agreement for Medication Assistance Services
HSMN NewsFeed - 16 Jan 2008
Teva Specialty Pharmaceuticals and UCB Announce U.S. Respiratory Collaboration Agreement
Teva Specialty Pharmaceuticals and UCB Announce U.S. Respiratory Collaboration Agreement
HSMN NewsFeed - 15 Jan 2008
American Academy of Ophthalmology Mourns Loss of Judah Folkman, MD, Pioneering Researcher
American Academy of Ophthalmology Mourns Loss of Judah Folkman, MD, Pioneering Researcher
HSMN NewsFeed - 15 Jan 2008
Talima Therapeutics Hires Martin Babler as President and Chief Executive Officer
Talima Therapeutics Hires Martin Babler as President and Chief Executive Officer
HSMN NewsFeed - 15 Jan 2008
Strativa Pharmaceuticals Acquires Commercialization Rights to Onconase(R) from Alfacell Corporation
Strativa Pharmaceuticals Acquires Commercialization Rights to Onconase(R) from Alfacell Corporation
HSMN NewsFeed - 15 Jan 2008
POZEN Submits Human Lymphocyte Study for Treximet(TM) (Formerly Known as Trexima(TM))
POZEN Submits Human Lymphocyte Study for Treximet(TM) (Formerly Known as Trexima(TM))
HSMN NewsFeed - 15 Jan 2008
First Head to Head Study Comparing Crestor(TM) and Lipitor(R) Effects on the Treatment of Atherosclerosis
First Head to Head Study Comparing Crestor(TM) and Lipitor(R) Effects on the Treatment of Atherosclerosis
HSMN NewsFeed - 14 Jan 2008
Three Rivers Pharmaceuticals(R), LLC Acquires Hepatitis C Drug Infergen(R) from Valeant Pharmaceuticals
Three Rivers Pharmaceuticals(R), LLC Acquires Hepatitis C Drug Infergen(R) from Valeant Pharmaceuticals
HSMN NewsFeed - 14 Jan 2008
Neurocrine Announces Appointment of Kevin Gorman, Ph.D., as President and Chief Executive Officer
Neurocrine Announces Appointment of Kevin Gorman, Ph.D., as President and Chief Executive Officer
HSMN NewsFeed - 14 Jan 2008
FDA Approves TYSABRI(R) for the Treatment of Moderate-to-Severe Crohn's Disease
FDA Approves TYSABRI(R) for the Treatment of Moderate-to-Severe Crohn's Disease
HSMN NewsFeed - 14 Jan 2008
Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Metaglip(R)
Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Metaglip(R)
HSMN NewsFeed - 14 Jan 2008
Joseph A. Mollica Named Chairman of Celator(R) Pharmaceuticals Board of Directors
Joseph A. Mollica Named Chairman of Celator(R) Pharmaceuticals Board of Directors
HSMN NewsFeed - 14 Jan 2008
Merck/Schering-Plough Pharmaceuticals Provides Results of the ENHANCE Trial
Merck/Schering-Plough Pharmaceuticals Provides Results of the ENHANCE Trial
HSMN NewsFeed - 14 Jan 2008
King Pharmaceuticals Reports FDA Approval of Revised Labeling Regarding Purity of THROMBIN-JMI(R)
King Pharmaceuticals Reports FDA Approval of Revised Labeling Regarding Purity of THROMBIN-JMI(R)
HSMN NewsFeed - 14 Jan 2008
Pfizer Receives Initial Communication from U.S. Patent and Trademark Office Regarding Lipitor Basic Patent
Pfizer Receives Initial Communication from U.S. Patent and Trademark Office Regarding Lipitor Basic Patent
HSMN NewsFeed - 14 Jan 2008
Encysive Pharmaceuticals Launches THELIN (sitaxentan sodium) in Belgium and Luxembourg
Encysive Pharmaceuticals Launches THELIN (sitaxentan sodium) in Belgium and Luxembourg
HSMN NewsFeed - 11 Jan 2008
Cadence Pharmaceuticals Announces Topline Results of Two Phase III Clinical Trials of Acetavance(TM)
Cadence Pharmaceuticals Announces Topline Results of Two Phase III Clinical Trials of Acetavance(TM)
HSMN NewsFeed - 10 Jan 2008
Inflazyme Pharmaceuticals Announces Appointment of Michael Liggett as a Director and Acting CEO
Inflazyme Pharmaceuticals Announces Appointment of Michael Liggett as a Director and Acting CEO
HSMN NewsFeed - 10 Jan 2008
FDA Accepts for Filing the BEMA(TM) Fentanyl NDA from BioDelivery Sciences
FDA Accepts for Filing the BEMA(TM) Fentanyl NDA from BioDelivery Sciences
HSMN NewsFeed - 10 Jan 2008
Teva Announces Departure of North American CEO William S. Marth to Become CEO of Teva North America
Teva Announces Departure of North American CEO William S. Marth to Become CEO of Teva North America
HSMN NewsFeed - 10 Jan 2008
LFB Biotechnologies to Collaborate with GTC Biotherapeutics on Coagulation Factor IX Program
LFB Biotechnologies to Collaborate with GTC Biotherapeutics on Coagulation Factor IX Program
HSMN NewsFeed - 10 Jan 2008
Cardinal Health Taps Teva Executive George Barrett to Lead Healthcare Supply Chain Services Sector
Cardinal Health Taps Teva Executive George Barrett to Lead Healthcare Supply Chain Services Sector
HSMN NewsFeed - 9 Jan 2008
BioAlliance Pharma Receives Market Approval for Loramyc(R) in the United Kingdom and Denmark
BioAlliance Pharma Receives Market Approval for Loramyc(R) in the United Kingdom and Denmark
HSMN NewsFeed - 8 Jan 2008
Quintiles Names Head of Strategic Research, Medical, Regulatory, and Safety Services
Quintiles Names Head of Strategic Research, Medical, Regulatory, and Safety Services
HSMN NewsFeed - 8 Jan 2008
FDA Approves Cialis(R) (tadalafil) for Once Daily Use for the Treatment of Erectile Dysfunction
FDA Approves Cialis(R) (tadalafil) for Once Daily Use for the Treatment of Erectile Dysfunction
HSMN NewsFeed - 8 Jan 2008
DRAXIS Names New President and Chief Executive Officer as well as New Chief Operating Officer
DRAXIS Names New President and Chief Executive Officer as well as New Chief Operating Officer
HSMN NewsFeed - 8 Jan 2008
OncoVista Innovative Therapies, Inc. Appoints J. Michael Edwards New Chief Financial Officer
OncoVista Innovative Therapies, Inc. Appoints J. Michael Edwards New Chief Financial Officer
HSMN NewsFeed - 8 Jan 2008
Artes Medical Names Dr. John F. Kay as Vice President, Engineering and Development
Artes Medical Names Dr. John F. Kay as Vice President, Engineering and Development
HSMN NewsFeed - 7 Jan 2008
Genzyme and Isis Announce Strategic Alliance Including Exclusive Worldwide License of Mipomersen
Genzyme and Isis Announce Strategic Alliance Including Exclusive Worldwide License of Mipomersen
HSMN NewsFeed - 7 Jan 2008
Baxter Announces Recombinant Factor IX Development Program For Hemophilia B
Baxter Announces Recombinant Factor IX Development Program For Hemophilia B
HSMN NewsFeed - 7 Jan 2008
John R. Riesenberger Joins MannKind as Corporate Vice President and Chief Commercialization Officer
John R. Riesenberger Joins MannKind as Corporate Vice President and Chief Commercialization Officer
HSMN NewsFeed - 7 Jan 2008
Callisto Pharmaceuticals Amends and Restates Atiprimod License Agreement with Genzyme
Callisto Pharmaceuticals Amends and Restates Atiprimod License Agreement with Genzyme
HSMN NewsFeed - 7 Jan 2008
Panacos Appoints Jane Pritchett Henderson Chief Financial and Business Officer
Panacos Appoints Jane Pritchett Henderson Chief Financial and Business Officer
HSMN NewsFeed - 7 Jan 2008
Alkermes Announces Agreement for the Commercialization of VIVITROL in Russia/CIS
Alkermes Announces Agreement for the Commercialization of VIVITROL in Russia/CIS
HSMN NewsFeed - 7 Jan 2008
Xeloda(R) Combination Therapy in Esophagogastric Cancer Highlighted in New England Journal of Medicine
Xeloda(R) Combination Therapy in Esophagogastric Cancer Highlighted in New England Journal of Medicine
HSMN NewsFeed - 7 Jan 2008
Romark Laboratories Names Emmet B. Keeffe, M.D. Vice President and Chief Medical Officer
Romark Laboratories Names Emmet B. Keeffe, M.D. Vice President and Chief Medical Officer
HSMN NewsFeed - 7 Jan 2008
Antares Pharma Develops Novel Pen Injector under New Agreement with Teva Pharmaceuticals
Antares Pharma Develops Novel Pen Injector under New Agreement with Teva Pharmaceuticals
